R. S. Beedimani and B. Kalmath, “Canagliflozin: a novel ‘glucuretic’ approach for the treatment of type 2 diabetes mellitus”, Int J Basic Clin Pharmacol, vol. 3, no. 3, pp. 578–580, Jan. 2017.